Shuttle Pharmaceuticals Holdings (SHPH) Accumulated Expenses (2022 - 2025)

Shuttle Pharmaceuticals Holdings' Accumulated Expenses history runs 4 years deep, the most recent figure standing at $7854.0 for Q3 2025.

• In Q3 2025, Accumulated Expenses rose 267.52% year-over-year to $7854.0; the TTM figure through Sep 2025 stood at $7854.0 (up 267.52% YoY), while the FY2024 annual figure was $1785.0, down 98.38% from the prior year.
• Accumulated Expenses was $7854.0 for Q3 2025 at Shuttle Pharmaceuticals Holdings, up from $7753.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $143676.0 in Q1 2024 to a low of $822.0 in Q3 2022.
• Historically, Accumulated Expenses has averaged $55121.8 across 4 years, with a median of $23328.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses jumped 12865.69% in 2023, then plunged 98.38% in 2024.
• A 4-year view of Accumulated Expenses shows it stood at $98135.0 in 2022, then gained by 12.55% to $110453.0 in 2023, then slumped by 98.38% to $1785.0 in 2024, then jumped by 340.0% to $7854.0 in 2025.
• The last three Accumulated Expenses figures came in at $7854.0 (Q3 2025), $7753.0 (Q2 2025), and $7653.0 (Q1 2025), per Business Quant data.